- Caladrius Biosciences, Inc. (NASDAQ: CLBS) rose 132.4% to $3.79 in pre-market trading. Caladrius Biosciences said it treated first patient in Phase 2b FREEDOM trial of CLBS16 for the treatment of coronary microvascular dysfunction.
- Steel Connect, Inc. (NASDAQ: STCN) rose 79% to $1.95 in pre-market trading after climbing over 36% on Tuesday.
- Lineage Cell Therapeutics, Inc. (NYSE: LCTX) shares rose 62% to $4.00 in pre-market trading after jumping over 14% on Tuesday.
- Daré Bioscience, Inc.. (NASDAQ: DARE) shares rose 56.9% to $3.70 in pre-market trading after climbing around 64% on Tuesday. Dare Bioscience, earlier during the month, filed for offer and sale of up to 6.4 million shares of common stock by Lincoln Park Capital Fund.
- ENDRA Life Sciences Inc. (NASDAQ: NDRA) shares rose 43.7% to $2.50 in pre-market trading after jumping over 65% on Tuesday. ENDRA Life Sciences, last week, was granted 13th US patent for its Taeus platform technology.
- Inuvo, Inc.. (NYSE: INUV) rose 36.6% to $1.98 in pre-market trading after jumping 123% on Tuesday. Inuvo reported the closing of its earlier announced registered direct offering for total gross proceeds of $8.0 million.
- Hall of Fame Resort & Entertainment Company (NASDAQ: HOFV) rose 28.1% to $2.37 in pre-market trading.
- PCTEL, Inc. (NASDAQ: PCTI) rose 25.7% to $11.16 in pre-market trading after jumping over 35% on Tuesday.
- Avinger, Inc. (NASDAQ: AVGR) rose 21.9% to $2.39 in pre-market trading. Avinger shares jumped over 33% on Tuesday after Aegis Capital raised its price target on the stock from $1 to $2.50. The company last week initiated the commercial launch of its Tigereye image-guided chronic total occlusion crossing system.
- AIkido Pharma Inc. (NASDAQ: AIKI) rose 18.2% to $1.30 in pre-market trading. Alkido Pharma said on January 12, 2021 the company did not obtain approval from stockholders that held a majority of issued and outstanding shares.
- Orbital Energy Group, Inc. (NASDAQ: OEG) rose 17.8% to $4.90 in pre-market trading. Orbital Energy Group reported the closing of its earlier announced registered direct offering.
- AutoWeb, Inc. (NASDAQ: AUTO) shares rose 17.5% to $3.49 in pre-market trading after climbing around 15% on Tuesday.
- Aptorum Group Limited (NASDAQ: APM) rose 16.4% to $3.70 in pre-market trading as the company received Health Canada clearance to initiate Phase 1 clinical trial for ALS-4, a small molecule drug for infections caused by staphylococcus aureus including MRSA.
- VYNE Therapeutics Inc. (NASDAQ: VYNE) shares rose 15.7% to $2.06 in pre-market trading after gaining over 6% on Tuesday.
- Reed’s, Inc. (NASDAQ: REED) rose 15.6% to $0.9236 in pre-market trading. Reed’s, last week, said it sees preliminary Q4 sales of $10.3 million.
- Novan, Inc. (NASDAQ: NOVN) shares rose 15.2% to $1.51 in pre-market trading. Novan, on Tuesday, announced its B-SIMPLE4 Phase 3 study reached 90% enrollment, with topline data targeted for Q2.
- Sorrento Therapeutics, Inc. (NASDAQ: SRNE) shares rose 15.1% to $10.85 in pre-market trading. Sorrento Therapeutics will be presenting preliminary results from an ongoing SARS-CoV-2 mutation surveillance program for its neutralizing antibodies currently in clinical and pre-clinical development for treatment of patients with COVID-19 disease.
- iClick Interactive Asia Group Limited (NASDAQ: ICLK) rose 15.1% to $16.00 in pre-market trading after climbing 18% on Tuesday.
- BEST Inc. (NYSE: BEST) rose 14.6% to $2.35 in pre-market trading.
- TransEnterix, Inc. (NYSE: TRXC) shares rose 13.8% to $3.97 in pre-market trading. TransEnterix shares jumped around 69% on Tuesday after the company announced it has received CE Mark approval for the Intelligent Surgical Unit that enables machine vision capabilities on the Senhance Surgical System..
- AMC Entertainment Holdings, Inc. (NYSE: AMC) rose 13.1% to $3.46 in pre-market trading. The movie theater company’s stock soared over 31% on Tuesday after it said it raised $100 million through first-lien, secured notes due 2026, as per a filing with the U.S. Securities and Exchange Commission.
- Netflix, Inc. (NASDAQ: NFLX) rose 11.8% to $561.51 in pre-market trading after the company reported better-than-expected Q4 sales and issued strong guidance for the first quarter. Its global streaming paid memberships climbed 21.9% year-over-year to 203.66 million during the quarter. A report also mentioned the company is exploring potential buybacks to return cash to shareholders.
- Isoray, Inc. (NYSE: ISR) rose 11.5% to $2.69 in pre-market trading after gaining over 21% on Tuesday. The company, earlier during the month, announced it received FDA 510(k) clearance for the use of C4 Imaging’s Sirius positive-signal MRI Markers with Isoray’s Cesium-131, brachytherapy seeds.
- CYREN Ltd. (NASDAQ: CYRN) rose 11.5% to $1.54 in pre-market trading after the company announced the availability of its next generation email security solution for Microsoft 365 through the Microsoft Azure Marketplace.
- Predictive Oncology Inc. (NASDAQ: POAI) shares rose 9.6% to $1.14 in pre-market trading. Predictive Oncology, on Tuesday, announced a $2.2 million registered direct offering priced at-the-market.
- Cyren Ltd (NASDAQ: CYRN) rose 8% to $1.49 in pre-market trading after the company announced the availability of its next generation email security solution for Microsoft 365 through the Microsoft Azure Marketplace.
- PACCAR Inc (NASDAQ: PCAR) rose 6% to $94.49 in pre-market trading after the company announced it formed a strategic partnership with Aurora to develop autonomous trucks.
Share this post:
Facebook
Twitter
LinkedIn
WhatsApp